Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali Volume 11 Issue 3 (2026)
RETROSPECTIVE ANALYSIS OF THE INHIBITOR FORM OF HEMOPHILIA A IN CHILDREN
МАХМУДОВА Дилором Салахитдиновна, ШАДИБЕКОВА Оксана Брониславовна, АЛМЕДОВА Наргиза Нигмаджановна, ДЕХКАНОВ Саттор Кахрамонович, МУСТАФАЕВ Арсений Русланович
Abstract
Baseline factor VIII activity level cannot serve as a reliable clinical predictor of inhibitor development. Given the high frequency of this complication, regular laboratory screening for antibodies is justified for all patients receiving replacement therapy, regardless of the severity of the disease phenotype.
гемофилия А, ингибиторная форма, фактор VIII, Bethesda, титр ингибиторных антителhemophilia A, inhibitor form, factor VIII, Bethesda units, inhibitor antibody titergemofiliya A, ingibitor shakli, VIII omil, Bethesda, ingibitor antitanalar titri
Metadata source: the journal's OAI-PMH archive · Sindex does not store the full text; it links to the source.